Inhibition of MYC has been postulated as one of the most promising anti-tumoral therapies. However, if some anti-inflammatory cells express MYC, would an anti-tumoral treatment targeting MYC facilitate subsequent inflammation-related disorders?
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292312 | PMC |
http://dx.doi.org/10.4161/21624011.2014.956013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!